Category: PSYCH NEWS

Ehave (EHVVF) Announces Inclusion in the 2021 Psychedelic Investor Guide

MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today that it...

Ehave (EHVVF) Announces Update On Ehave Medical App With The Launch Of Covid Vaccine Passport Going Live Shortly

Ehave's Covid Passport provides small businesses a tool to verify Covid-19 vaccination, and a suite of products to improve both the mental and overall health of individuals.

We Just Got Closer to Understanding Why Ketamine Is Such a Powerful Antidepressant (Science Alert).

CARLY CASSELLA 13 AUGUST 2021 Oral ketamine, known both as an anesthetic and a recreational drug, has recently emerged as a highly promising, rapid treatment for severe depression.

Adding Ehave (EHVVF) to Psychedelic Stock Watch List.

Mental Health and Wellness Incubator Set to Launch Four Initiatives.Trading at Year Low.Launching Clinical Trial With Brain Scientific to Monitor Ketamine Efficacy.Launching Clinical Trial With Mycotopia Therapies and PsyBioMed.Launching...

CBS News: Inside a Psychedelic Ketamine Therapy Sessions (Video).

Therapy Treatment Performed by Ehave’s (EHVVF) Chief Medical Office Dr. Jeffrey Kamlet Received Rave Reviews and Offers the Potential to Save Lives. MIAMI BEACH, Fla. (CBS12) — Last month,...
Most Popular

Ehave, Inc. Announces its KetaDASH Mobile Unit Delivered to Miami Beach.

MIAMI, June 03, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced...

Australian Icannex (IHL:ASX) Headed to NASDAQ?

Incannex completes Phase 2 trial for its cannabinoid drug for sleep apnea, flags Nasdaq listing in 2022

Testimonial: The Ibogaine Clinic, Playa Del Carmen